Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 566 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Exelixis makes Cometriq available in US

Diplomat Specialty Pharmacy is distributing the product across the US. Cometriq that is developed to inhibit the activity of tyrosine kinases including RET, MET and VEGFR2, obtained FDA